Medical Technology

@xconomy.com 3 years ago

Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs

@xconomy.com 4 years ago

EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device

@xconomy.com 4 years ago

Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus

@xconomy.com 4 years ago

DTx Pharma Raises $10.6M to Advance New Way to Deliver RNA Drugs

@xconomy.com 4 years ago

Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More

@xconomy.com 4 years ago

Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further

@techcrunch.com 4 years ago

Neurobehavioral health company Blackthorn pulls in $76 million from GV to treat mental disorders

@xconomy.com 4 years ago

Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More

@xconomy.com 5 years ago

Rani’s “Robotic Pill” for Biologics Clears First Hurdle in Humans

@xconomy.com 5 years ago

Rani’s “Robotic Pill” for Biologics Clears First Hurdle in Humans

@xconomy.com 5 years ago

Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More

@xconomy.com 5 years ago

Synthorx Files for IPO to Advance Enhanced Cytokine Drugs

@xconomy.com 5 years ago

Verana Health Lands $30M Financing Led By GV, Adds Miki Kapoor as CEO

@xconomy.com 6 years ago

Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs

@techcrunch.com 6 years ago

Reverie Labs uses new machine learning algorithms to fix drug development bottlenecks

@techcrunch.com 6 years ago

Life sciences startup Avro aims to deliver drugs to children and the elderly through skin patches